CD73 inhibitor

0 marketed 4 in Phase 2

This page covers all CD73 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD73.

Targets

Phase 2 pipeline (4)

BGB-DXP593 · BeiGene · Oncology
BGB-DXP593 is a small molecule inhibitor targeting the CD73 enzyme.
AZD6094 · Samsung Medical Center · Oncology
AZD6094 is a small molecule inhibitor of the CD73 enzyme.
CD07223 · Galderma R&D · Oncology
CD07223 is a small molecule targeting the CD73 enzyme.
AZD5423 · AstraZeneca · Oncology
AZD5423 is a small molecule inhibitor of the CD73 enzyme.